| [human immunodeficiency virus infections (hiv-1 and hiv-2) in dakar. epidemiologic and clinical aspects]. | the authors report on the results of an investigation carried out on 109 hiv seropositives ascertained by the dakar central hospital between february 20, 1987 and may 31, 1988. these seropositives affected 44 patients with aids (0.78% of admitted patients) and 65 seropositive people of which 43 blood donors (1.35% of donors). both viruses are present in about equal number: 50 hiv1 seropositives, 44 hiv2 seropositives, and 15 composite seropositives. sex-ratio is 3,9 in favour of males; this figu ... | 1988 | 3221781 |
| clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (hiv-2). | we studied the clinical status and certain hematologic and immunologic parameters in healthy prostitutes from dakar, senegal who were seropositive for antibodies to human immunodeficiency virus type-2 (hiv-2). generalized lymphadenopathy and clinical signs or symptoms similar to those which are seen with human immunodeficiency virus type-1 (hiv-1) infection were not present. comparison to seronegative prostitutes and minor surgery control patients were made and significant elevations were seen i ... | 1988 | 3259142 |
| [preliminary study of human herpesvirus type 8 infection in pregnant women in dakar (senegal)]. | hhv8 was discovered in 1994 and few studies on this virus have been conducted in africa. the virus is related to kaposi sarcoma, an opportunistic affection occurring during hiv infection. no studies have been carried out on this subject in senegal, a country known for its low ks prevalence even among people living with hiv/aids. thus it will be interesting to explore this field. the aim of our study has been first, to demonstrate the presence of hhv8; second, to evaluate sero-prevalence of the i ... | 2001 | 11681216 |
| emergence of multiclass drug-resistance in hiv-2 in antiretroviral-treated individuals in senegal: implications for hiv-2 treatment in resouce-limited west africa. | the efficacy of various antiretroviral (arv) therapy regimens for human immunodeficiency virus type 2 (hiv-2) infection remains unclear. hiv-2 is intrinsically resistant to the nonnucleoside reverse-transcriptase inhibitors and to enfuvirtide and may also be less susceptible than hiv-1 to some protease inhibitors (pis). however, the mutations in hiv-2 that confer arv resistance are not well characterized. | 2009 | 19143530 |